Showing posts with label phosphocreatine. Show all posts
Showing posts with label phosphocreatine. Show all posts

Friday, 1 August 2008

Could these drugs...

... be something that would work for CFS?

Researchers Identify Drugs that Enhance Exercise Endurance HHMI News - July 31, 2008

... Researchers have identified two drugs that mimic many of the physiological effects of exercise. The drugs increase the ability of cells to burn fat and are the first compounds that have been shown to enhance exercise endurance.

Both drugs can be given orally and work by genetically reprogramming muscle fibers so they use energy better and contract repeatedly without fatigue. In laboratory experiments, mice taking the drugs ran faster and longer than normal mice on treadmill tests. Animals that were given AICAR, one of the two drugs, ran 44 percent longer than untreated animals. The second compound, GW1516, had a more dramatic impact on endurance, but only when combined with exercise.

Ronald M. Evans, the Howard Hughes Medical Institute investigator who led the study, said drugs that mimic exercise could offer potent protection against obesity and related metabolic disorders. They could also help counter the effects of devastating muscle-wasting diseases like muscular dystrophy. Evans and his colleagues, who are at the Salk Institute for Biological Studies, published their findings on July 31, 2008, in an advance online publication in the journal Cell. ...

ZenMaster

Tuesday, 21 August 2007

Here are some references...

...to the original work I talked about in my previous post. If anyone is interested I can send you a more complete list. Just send me an e-mail and ask for it!

ZenMaster

References related to energy metabolism in CFS:

  • Assessment of cardiac metabolic disorders with positron emission tomography.

    Waldenstrom A, Langstrom B. Curr Opin Cardiol. 1991 Dec;6(6):965-71. Review. PMID: 10150067 [PubMed - indexed for MEDLINE]

  • Human uterine smooth muscle exhibits a very low phosphocreatine/ATP ratio as assessed by in vitro and in vivo measurements.

    Steingrimsdottir T, Ericsson A, Franck A, Waldenstrom A, Ulmsten U, Ronquist G. Eur J Clin Invest. 1997 Sep;27(9):743-9. PMID: 9352245 [PubMed - indexed for MEDLINE]

  • Ionophoric action on the cellular membrane as a pathophysiological mechanism in syndrome X: myth or reality?

    Waldenstrom A, Ronquist G. J Intern Med. 1995 Sep;238(3):187-9. No abstract available. PMID: 7673847 [PubMed - indexed for MEDLINE]

  • Disturbed energy balance in skeletal muscle of patients with untreated primary hypertension.

    Ronquist G, Soussi B, Frithz G, Schersten T, Waldenstrom A. J Intern Med. 1995 Aug;238(2):167-74. PMID: 7629485 [PubMed - indexed for MEDLINE]

  • Coxsackie B3 myocarditis induces a decrease in energy charge and accumulation of hyaluronan in the mouse heart.

    Waldenstrom A, Fohlman J, Ilback NG, Ronquist G, Hallgren R, Gerdin B. Eur J Clin Invest. 1993 May;23(5):277-82. PMID: 8394817 [PubMed - indexed for MEDLINE]

  • Phosphocreatine turnover and pH balance in forearm muscle of patients wit syndrome X.

    Soussi B, Schersten T, Waldenstrom A, Ronquist G. Lancet. 1993 Mar 27;341(8848):829-30. No abstract available. PMID: 8096030 [PubMed - indexed for MEDLINE]

  • Angina pectoris patients with normal coronary angiograms but abnormal thallium perfusion scan exhibit low myocardial and skeletal muscle energy charge.

    Waldenstrom A, Ronquist G, Lagerqvist B. J Intern Med. 1992 Apr;231(4):327-31. PMID: 1588255 [PubMed - indexed for MEDLINE]

  • Low energy charge in human uterine muscle.

    Wedenberg K, Ronquist G, Waldenstrom A, Ulmsten U. Biochim Biophys Acta. 1990 Jan 29;1033(1):31-4. PMID: 2137351 [PubMed - indexed for MEDLINE]